BioSpace News Archive

Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic

Industry-leading CME provider is bridging the education gaps internationally to give clinicians access to its world-renowned faculty, latest insights and developments

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced the initiation of a Phase 1/2a trial of the company’s lead product candidate, PIPE-505, a small molecule gamma secretase inhibitor (GSI), in sensorineural hearing loss (SNHL) associated with hearing speech in noisy environments.

Availability of Oral Cancer Screening Technology to More Patients Can Help Save Lives

Amidst the COVID-19 pandemic, GLOBAL helps provide economic support, shelter, food, and medical care to Down Syndrome Organizations and the Families they serve in 23 states and 4 countries

On the heels of winning the Security Industry Association’s (SIA) New Product Showcase award for the Best Emerging Technology in 2020, BioConnect is thrilled to be selected into the MaRS Momentum Program. It is a launchpad for global powerhouse companies. It is an exclusive program designed to support the executives of high growth companies on their way to exceeding $100 million in revenue in the next five years. The program,

Lincoln Property Company (“LPC”), in partnership with MetLife Investment Management is pleased to announce that construction has commenced on a 140,000 square foot state-of-the-art life science/office facility at 300 Third Avenue in Waltham, MA.

Steps include a 50% increase in reimbursement rates for child psychiatrists and permanently paying for telehealth visits at in-person rates

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that the Company has expanded its product offerings to include Cannabidiol (“CBD”) infused

Specialized cells at the edge of growing skin cancers reduce immune response, Stanford researchers have reported in Cell.